ONFAB

ONFAB is a specialized medical device company providing critical flexible containment solutions for the pharmaceutical manufacturing sector, with a focus on high-potent active pharmaceutical ingredients (HPAPIs). Its core value proposition lies in delivering cost-effective, GMP-compliant, and rapidly deployable isolator systems that enhance operator safety and manufacturing efficiency. As part of the Savillex group, ONFAB leverages a global manufacturing footprint and deep process expertise to serve blue-chip clients like Pfizer, AstraZeneca, and Sanofi. The company's business model is built on providing engineered equipment and turnkey services, positioning it as a key enabler for the growing high-potent drug market.

Bespoke flexible containment and single-use isolator systems for pharmaceutical manufacturing, achieving high-potent containment (OEB 4/5, <30 ng/m³). Solutions include process-integrated and standalone isolators for weighing, milling, sizing, and handling explosive powders.

ONFAB competes in the niche market for flexible pharmaceutical containment against other specialized engineering firms offering both rigid and flexible isolator solutions. Its key differentiators are its focus on bespoke, flexible designs, rapid deployment (5-6 weeks), and a global manufacturing and service footprint as part of the Savillex group.